The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia

Advancing therapy for hypercholesterolemia

(2010) Konstantinos Toutouzas et al.   EXPERT OPINION ON PHARMACOTHERAPY

Fasting reduces plasma proprotein convertase, subtilisin/kexin type 9 and cholesterol biosynthesis in humans

(2010) Jeffrey D. Browning et al.   JOURNAL OF LIPID RESEARCH

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study

(2010) Rima Kaddurah-Daouk et al.   Metabolomics

The LDL Receptor

(2009) Joseph L. Goldstein et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?

(2009) R. Bitzur et al.   DIABETES CARE

Genetic and Metabolic Determinants of Plasma PCSK9 Levels

(2009) Susan G. Lakoski et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Molecular basis of PCSK9 function

(2008) Gilles Lambert et al.   ATHEROSCLEROSIS

Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies

(2008) Julien Labreuche et al.   ATHEROSCLEROSIS

Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required

(2008) H. Robert Superko et al.   CIRCULATION

Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins

(2008) Sandrin C. Bergheanu et al.   CURRENT MEDICAL RESEARCH AND OPINION

Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test

(2008) Edward P. Weiss et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake

(2008) Leanne Hodson et al.   PROGRESS IN LIPID RESEARCH